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SCF ubiquitin ligases recruit substrates for deg-
radation via F box protein adaptor subunits.
WD40 repeat F box proteins, such as Cdc4 and
b-TrCP, contain a conserved dimerization motif
called the D domain. Here, we report that the D
domain protomers of yeast Cdc4 and human
b-TrCP form a superhelical homotypic dimer.
Disruption of the D domain compromises the
activity of yeast SCFCdc4 toward the CDK inhib-
itor Sic1 and other substrates. SCFCdc4 dimer-
ization has little effect on the affinity for Sic1
but markedly stimulates ubiquitin conjugation.
A model of the dimeric holo-SCFCdc4 complex
based on small-angle X-ray scatter measure-
ments reveals a suprafacial configuration, in
which substrate-binding sites and E2 catalytic
sites lie in the same plane with a separation of
64 A˚ within and 102 A˚ between each SCFmono-
mer. This spatial variability may accommodate
diverse acceptor lysine geometries in both sub-
strates and the elongating ubiquitin chain and
thereby increase catalytic efficiency.
INTRODUCTION
Theubiquitin-proteasome system (UPS) governs the levels
of many cellular proteins via a canonical cascade of en-
zymes termed E1, E2, and E3, which activate and then
conjugate ubiquitin to its substrates (Hershko and Cie-
chanover, 1998). TheE3 enzymes, also referred to as ubiq-
uitin ligases, catalyze the final step in ubiquitin transfer in
a substrate-specificmanner. Themultitude of E3 enzymes
can be parsed into two main classes, as characterized bythe presence of either a HECT domain or a RING domain.
The HECT domain forms a catalytically essential thioester
with ubiquitin, whereas the RING domain provides a dock-
ing site for E2 enzymes, which provide catalytic activity
(Pickart, 2001). The E3 superfamily has diversified through
evolution, in particular through the elaboration of specific
substrate adaptor proteins. The prototypical such system
is the Skp1–Cdc53/cullin–F box protein (SCF) ubiquitin
ligase family, which is built on a central apparatus com-
posed of the linker protein Skp1, the scaffold protein
Cdc53/Cul1, and the RING-H2 domain protein Rbx1/
Roc1/Hrt1 (Willems et al., 2004; Petroski and Deshaies,
2005a). A large cohort of adaptor subunits called F box
proteins recruit specific substrates to the SCF core com-
plex, often in a phosphorylation-dependent manner (Bai
et al., 1996; Patton et al., 1998). F box proteins contain an
N-terminal motif called the F box, which binds Skp1 (Bai
et al., 1996), and a C-terminal protein interaction domain
that binds substrates, typically leucine-rich repeats (LRRs)
or WD40 repeats (Feldman et al., 1997; Skowyra et al.,
1997). A number of related ubiquitin ligase complexes fol-
low on the SCF theme, both in overall architecture and in
subunit conservation. These SCF-like complexes, some-
times referred to as the cullin-RING ligases (CRLs), include
the Anaphase-Promoting Complex/Cyclosome and com-
plexes built on Cul2, Cul3, Cul4A, Cul5, and Cul6 scaffolds
(Pintard et al., 2004; Willems et al., 2004; Petroski and De-
shaies, 2005a). All told, the CRL class of E3s likely targets
many hundreds of proteins for degradation.
SCF complexes eliminate cyclins and cyclin-dependent
kinase (CDK) inhibitors at various points in the cell cycle
(Willems et al., 2004). In yeast, the CDK inhibitor Sic1
must be degraded in order for the onset of B type cyclin
CDK (Clb-Cdc28) activity and consequent DNA replication
(Schwob et al., 1994). Sic1 ubiquitination is triggered upon
its phosphorylation in late G1 phase by G1 cyclin CDK
(Cln-Cdc28) activity; versions of Sic1 that lack multipleCell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc. 1165
CDK phosphorylation sites are stabilized and hence arrest
cells in G1 phase (Verma et al., 1997). Sic1 specifically in-
teracts with the WD40 domain of the F box protein Cdc4
(Feldman et al., 1997; Skowyra et al., 1997) but only if at
least six of the nine CDK sites in Sic1 are phosphorylated
(Nash et al., 2001). The threshold for Sic1 phosphorylation
derives from the fact that all nine natural Cdc4 phospho-
degron (CPD) sites in Sic1 have hydrophobic and electro-
static conflicts with the Cdc4-binding pocket (Orlicky
et al., 2003). Other budding yeast Cdc4 substrates, includ-
ing the Cln-Cdc28 inhibitor Far1, the replication protein
Cdc6, and the transcription factor Gcn4, are also de-
graded in a phosphorylation-dependent manner (Willems
et al., 2004). The fission yeast homologs of Cdc4, called
Pop1 and Pop2, target the CDK inhibitor Rum1 and the
replication factor Cdc18 (Kominami et al., 1998; Wolf
et al., 1999). Other well-characterized F box proteins in
budding yeast include the WD40 protein Met30, which
inactivates the transcription factor Met4, and the LRR
protein Grr1, which targets phosphorylated forms of the
G1 cyclins Cln1 and Cln2 (Patton et al., 1998; Willems
et al., 2004).
In metazoans, hCdc4/Fbw7 targets phosphorylated
forms of cyclin E for degradation (Koepp et al., 2001;
Moberg et al., 2001; Strohmaier et al., 2001). A high-affin-
ity consensus CPD motif centered on Thr380 is a primary
determinant for degradation of cyclin E, although other
phosphoepitopes also contribute to cyclin E recognition
(Welcker et al., 2003; Ye et al., 2004). Loss of Cdc4 func-
tion deregulates cyclin E-CDK2activity and is likely a caus-
ative mutation in a variety of human cancers (Moberg
et al., 2001; Strohmaier et al., 2001; Spruck et al., 2002;
Rajagopalan et al., 2004). Additional important substrates
that are targeted for degradation by Cdc4 orthologs in a
phosphorylation-dependent manner include the growth-
regulated transcription factors c-Myc and c-Jun, the de-
velopmental regulator Notch, the sterol biosynthesis reg-
ulator SREBP, and the presenilins (Ang and Harper, 2005).
The mechanism of ubiquitin transfer to the substrate
remains an outstanding general issue. Kinetic analysis of
the Sic1 ubiquitination reaction indicates that the reaction
proceeds in two distinct phases, namely a slow initiation
step followed by fast elongation of the polyubiquitin chain
(Petroski and Deshaies, 2005b). The particular choice of
the multiple potential acceptor lysine residues in Sic1
also influences the kinetics of the reaction (Petroski and
Deshaies, 2003). Structure determination of several E2/E3
complexes has shown that a large gap of 50–60 A˚ typically
separates the catalytic site and the substrate-binding site
(Zheng et al., 2000, 2002; Orlicky et al., 2003; Wu et al.,
2003). These substantial distances may help accommo-
date the large ubiquitin moiety during catalysis and/or al-
low elongation of the ubiquitin chain (Petroski et al., 2006).
Higher-order structure of ubiquitin ligases is an impor-
tant but poorly understood feature of the ubiquitination
reaction. Notably, all CRL structures solved to date con-
tain truncated subunits, which may affect intercomplex in-
teractions. In particular, the WD40 class of F box proteins1166 Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc.contain a small conserved motif called the D domain,
which mediates Pop1/2, b-TrCP, Met30, and Cdc4 dimer-
ization (Kominami et al., 1998; Wolf et al., 1999; Suzuki
et al., 2000; Dixon et al., 2003). Here, we determine the
structure of the D domain and demonstrate that SCF di-
merization facilitates ubiquitin conjugation but not sub-
strate recognition. A model based on small-angle X-ray
scattering (SAXS) data suggests that the two substrate-
binding sites and the two E2 catalytic sites in the dimeric
holo-SCFcdc4 complex form an interaccessible coplanar
surface. We posit that the bivalent geometry of the SCF
structure imposed by the D domain–F box linkage pro-
vides variable substrate-binding site-to-catalytic site dis-
tances and thereby facilitates ubiquitin conjugation to
diverse acceptor lysine residues.
RESULTS
Structure of the D Domain Dimer
A 45 amino acid motif immediately N-terminal to the F box
is highly conserved amongst WD40 repeat F box proteins
from yeast to human (Figure 1A). This motif corresponds
to the previously identified D domain that mediates dimer-
ization of human b-TrCP1 and b-TrCP2 (Suzuki et al.,
2000). The D domain also occurs in proteins that do not
contain an F box, such as Vts1, a SAM domain RNA-bind-
ing protein in yeast (Aviv et al., 2003). Based on sequence
alignments, we expressed the minimal D domain from
several proteins for crystallization trials. The D domains of
yeast Cdc4 and human b-TrCP1 were readily crystallized
and solved to resolutions of 2.5 A˚ and 2.4 A˚, respectively
(Table 1).
The overall Cdc4 and b-TrCP D domain structures are
very similar (Figure 1B). Each D domain protomer consists
of three a helices that self-associate in a right-handed su-
perhelical manner to form a parallel dimer. This arrange-
ment places both the N andC termini of the two protomers
in close proximity. The dimer interfaces of the Cdc4 and
b-TrCP structures bury 2963 A˚2 and 3917 A˚2 of surface
area, respectively. The overall hydrophobic nature of the
D domain dimer interface is highly conserved, but individ-
ual residues that comprise the interface vary drastically:
only 2 of 16 hydrophobic core residues are conserved be-
tween the D domains of yeast Cdc4 and human b-TrCP.
The absence of specific residue conservation at the dimer
interface suggests that the D domain may accommodate
considerable interaction specificity. Indeed, we observe
predominantly homotypic interactions between the iso-
lated D domains of Cdc4, b-TrCP, Met30, and Vts1 (Fig-
ure S1 available with this article online).
A minimal linker typically connects the D domain and
the F box domain (Figure 1A). In Cdc4, there are only two
residues between the last ordered helical residue in the D
domain (Lys271) and the first ordered helical residue in the
F box domain (Leu274, PDBID = 1NEX) structures. Simi-
larly, in b-TrCP there are only three unstructured resides
between the D domain (Leu140) and F box domain
(Asp143, PDBID = 1P22) structures. This feature severely
Figure 1. Structure of the D Domain
Dimer
(A) Structure-based sequence alignments.
Secondary structure elements for the b-TrCP
and Cdc4 D domains are indicated; a kink in
helix a2 of Cdc4 is denoted by a wedge; con-
served hydrophobic residues are highlighted
in yellow; residues mutated in this study are
indicated by red squares.
(B) Ribbons representations of two D domain
dimer structures. Top: Red and pink indicate
the D domain protomers of yeast Cdc4222–273.
Middle: Blue and cyan indicate the D domain
protomers of b-TrCP92–143. Bottom: Overlay
of D domain representations for Cdc4 and
b-TrCP.constrains the relative orientations that can be sampled by
the D domain and F box. Moreover, because both helix a3
of the Cdc4 and b-TrCP D domain and the first helix of the
Cdc4 and b-TrCP F box exhibit very similar relative orien-
tations in their respective structures, full-length Cdc4 and
b-TrCP likely form similar higher-order dimeric structures.
Notwithstanding the short linker between the D domain
and F box, repeated attempts to crystallize the entire D
domain–F box region have failed. The crucial matter of
how the D domain orients the two SCF monomers in a
dimer is addressed below.
Cdc4 Dimerizes through the D Domain
To precisely determine the relationship between D domain
structure and function, we mutated core structural resi-
dues in the Cdc4 D domain and assessed effects on inter-
actions in vivo. Coprecipitation analysis with differentially
tagged versions of Cdc4 demonstrated that wild-typeCCdc4 failed to interact with Cdc4L250E/V251E, which con-
tains point mutations at two highly conserved residues
that lie in the D domain dimer interface (Figure 2A). Gel fil-
tration, analytical ultracentrifugation, and coprecipitation
of the isolated recombinant D domains, as well as larger
D domain-containing fragments, of Cdc4, Met30, and
b-TrCP1/2 demonstrated that the D domain mediates di-
merization in a predominantly homotypic fashion (Figures
S1 and S2A–S2C). Coprecipitation of differentially tagged
Cdc53 complexes from cell extracts revealed that Cdc53
self-associates in the context of wild-type Cdc4 and
Cdc4222–744 but not monomeric Cdc4263–744 (Figure 2B).
Consistently, purified recombinant SCFCdc4 migrated as
a dimer under velocity gradient sedimentation, whereas
SCFCdc4(L250E/V251E) migrated as a monomer (Figure S3).
The corresponding conserved residues in the D domain
of Met30 are also required for Met30 dimer formation
and function in vivo (Figure S4), as suggested by previousell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc. 1167
mutagenic analysis (Dixon et al., 2003). Thus, the D
domain mediates dimerization of various SCF complexes
in vivo and in vitro.
Dimerization Is Required for SCFCdc4 Function
In Vivo and In Vitro
Alleles encodingmonomericCdc4263–744, Cdc4L250E/V251E,
and Cdc4L246E/L247E expressed from the CDC4 promoter
failed to complement a cdc4D mutation, indicating the
essential role of SCFCdc4 dimerization in vivo (Figure 2C).
Correspondingly, the in vivo degradation of Sic1 and of
another Cdc4 substrate, the transcription factor Gcn4,
were compromised in a strain engineered to conditionally
express only the monomeric Cdc4L250E/V251E version
(Figure 2D). Artificial dimerization of the D domain mutants
by GST, which also juxtaposes C-terminal regions in close
proximity (McTigue et al., 1995), complemented the
growth defect of a cdc4-1 strain (Figure 2E) but not a
cdc4D strain (data not shown). Notably, insertion of a lon-
germore flexible linker (GST-5G) compromised function of
the GST-Cdc4263–744 fusion (Figure 2E).
We assessed the ability of various recombinant SCFCdc4
complexes to ubiquitinate phosphorylated Sic1 in vitro
Table 1. D Domain Data Collection and Refinement
Statistics
Yeast Cdc4 Human b-TrCP
Wavelength (A˚) 0.97888 0.97906
Resolution (A˚) 2.5 2.4
Rsym (%) 5.2 (17.4) 5.0 (24.6)
Total reflections 30422 21650
Unique reflections 8181 11999
Completeness (%) 97.8 (88.8) 97.2 (97)
I/s 21.2 (8.5) 18.8 (3.2)
Refinement
Resolution range (A˚) 50–2.5 20–2.5
Reflections 7708 10345
R factor/Rfree (%) 23.1/27.4 24/26.7
Rms Deviations
Bonds (A˚) 0.004 0.016
Angles () 0.02 1.54
Space group P61
a = b = 37.8 A˚,
c = 298.1 A˚
a = b = 90,
g = 120
P43212
a = b = 71.3 A˚,
c = 116.3 A˚
a = b = g = 90
Ramachandran Data
Most favored 89.4% 98.9%
Additionally allowed 10.6% 1.1%
Generously allowed 0.0% 0.0%
Disallowed 0.0% 0.0%1168 Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc.(Figure 2F). In contrast to the robust conversion of Sic1
into high-molecular-mass polyubiquitin conjugates by
wild-type SCFCdc4, only partial ubiquitination was ob-
served with SCFCdc4(263–744), which lacks the D domain.
Artificial dimerization of Cdc4263–744 with the shorter linker
fusion to GST restored in vitro polyubiquitination of Sic1,
although reaction efficiency was reduced compared to
wild-type Cdc4 (see Figure S2D for a detailed reaction
time course). In vitro activity of the longer linker version
of GST was further compromised, as in vivo. The require-
ment for SCF dimerization in vitro was not unique to Sic1,
as both Gcn4 and another known Cdc4 substrate, the
CDK inhibitor Far1, exhibited defective ubiquitination by
the monomeric SCFCdc4(263–744) complex (Figure 2G). In
contrast, a recently reported Cdc4 substrate, the Sir2 ho-
molog Hst4 (Tang et al., 2005), was efficiently ubiquiti-
nated by the SCFCdc4 monomer, suggesting that perhaps
some substrates are largely immune to the dimerization
requirement. This latter result also demonstrated that the
monomer was not intrinsically defective in catalysis.
Monomeric SCFCdc4 Is Deficient in Ubiquitin Chain
Initiation and Elongation
We explored the requirement for dimerization in catalysis
by a detailed kinetic analysis of the Sic1 ubiquitination re-
action in vitro. Monomeric SCFCdc4(L250E/V251E) was most
noticeably defective in the production of high-molecular-
weight ubiquitin conjugates on Sic1 but was also some-
what compromised in its ability to add initial conjugates
(Figure 3A). As wild-type Sic1 is polyubiquitinated by
SCFCdc4 on multiple lysine residues (Petroski and De-
shaies, 2003), these partially ubiquitinated Sic1 species
might derive from addition of a few ubiquitin moieties to
several acceptor lysine residues or from efficient chain
extension on just one or two residues. To assess the rates
of initiation per se, we performed reactions using a version
of ubiquitin that lacks the Lys48 acceptor residue neces-
sary for chain elongation by Cdc34. The monomeric
SCFCdc4(L250E/V251E) enzyme exhibited a modest defect
in the rate of monoubiquitin-Sic1 formation (Figure 3B).
Most noticeably, SCFCdc4(L250E/V251E) appeared unable to
access the full repertoire of acceptor lysines on Sic1, as
indicated by the prevalence of lower-molecular-weight
conjugates formed relative to wild-type SCFCdc4 reac-
tions. To examine effects of dimerization on conjugation
to a single lysine residue, we used a version of Sic1 that
contains only Lys36 (Petroski and Deshaies, 2003). In
the presence of wild-type ubiquitin, Sic1(K36) reactions
reached a plateau after addition of five ubiquitin moieties,
suggesting a severe defect in chain elongation (Figure 3C);
moreover, the addition of the second and third ubiquitin
moieties appeared to be a fast step as di- and triubiquiti-
nated intermediates were barely detectable. Analogous
Sic1(K36) reactions with chain-terminating ubiquitin re-
vealed a strong kinetic delay and incomplete monoubiqui-
tination over the reaction time course (Figure 3D). Taken
together, these results suggest that optimal access to
different substrate lysine residues, in both initiation and
Figure 2. Dimerization Is Required for SCFCdc4 Function In Vivo and In Vitro
(A) The indicated versions of Cdc4 were expressed from the CDC4 promoter on a CEN plasmid in a cdc4D strain. Complexes were captured on anti-
FLAG resin and blotted with an anti-Cdc4 polyclonal antibody.
(B) The indicated epitope-tagged proteins were expressed in a wild-type strain, immunoprecipitated with anti-FLAG antibody, eluted and recaptured
on resin with anti-HA antibody, and then blotted with indicated antibodies.
(C) The indicated wild-type and D domain mutation alleles of CDC4 were expressed from the CDC4 promoter on a CEN plasmid in a cdc4D <CDC4
URA3> shuffle strain and grown in either –trp -ura medium (top) or 5-FOA medium (bottom).
(D) Wild-type andCDC4L250E/V251E strains bearing either aGAL1-SIC1 orGAL1-GCN4FLAG construct were grown in either raffinose (indicated by R) or
galactose, followed by repression in glucose medium for the indicated time points. Sic1 was detected with polyclonal anti-Sic1 antibody; Gcn4 was
detected with anti-FLAG antibody. Asterisk indicates Sic1 degradation product; # indicates nonspecific crossreactive species.
(E) Complementation of a cdc4-1 strain at the nonpermissive temperature by GAL1-GST–CDC4 fusion alleles. GST constructs had a 13 residue in-
tervening linker sequence between theGST andCDC4 coding sequences; GST-5G constructs had a 21 residue intervening linker sequence including
a stretch of five Gly residues. Cells were serially diluted and incubated on either galactose medium at 34C or glucose medium at 25C for 3 days.
(F) The indicated wild-type and D domain deletion versions of recombinant SCFCdc4 produced in insect cells were assayed for ability to ubiquitinate
phosphorylated Sic1 in vitro.
(G) In vitro ubiquitination of indicated Cdc4 substrates by either dimeric SCFCdc4(222–744) or monomeric SCFCdc4(263–744).Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc. 1169
elongation steps, depends on the dimeric configuration of
SCFCdc4.
SCFCdc4 Dimerization Is Not Required
for Substrate Recognition
Versions of Cdc4 that are defective for substrate interac-
tion might be expected to form nonproductive heterodi-
meric complexes. To test this notion, we overexpressed
a Cdc4 mutant that lacks a crucial Arg residue in the bind-
ing pocket (Cdc4R485A) and is thus unable to bind even
high-affinity CPD peptides (Nash et al., 2001). High-level
induction of aGAL1-CDC4R485A allele in a cdc4-1 temper-
ature-sensitive strain moderately reduced growth rate at
Figure 3. Monomeric SCFCdc4 Is Defective in Initiation and
Elongation Steps of the Ubiquitin Conjugation Reaction
(A) Time course of Sic1 ubiquitination by dimeric SCFCdc4 or mono-
meric SCFCdc4 (L250E/V251E). Products were detected with anti-Sic1
antibody.
(B) As in (A), except with Ub(K48R).
(C) UbiquitinationbydimericSCFCdc4 ormonomericSCFCdc4(L250E/V251E)
of a version of Sic1 that lacks all acceptor lysine residues except Lys36.
(D) As in (C), except with Ub(K48R). For Ub(K48R) reactions, aliquots
were treated with N-ethylmaleimide (NEM) to inactivate E1 and E2 en-
zymes and then with lambda phosphatase to collapse phospho-Sic1
isoforms prior to detection with anti-Sic1 antibody. Sic1(K0) lacks all
lysine residues and serves as a negative control.1170 Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc.the semipermissive temperature and caused an accumu-
lation of multiple elongated buds, which are diagnostic of
a Sic1 degradation defect (Figure 4A). This phenotype
was alleviated by introduction of a D domain mutation
into the same allele (i.e., Cdc4R485A/L250E/V251E), demon-
strating that Cdc4R485A interferes with SCFCdc4 function
by formation of compromised heterodimers. Titration of
SCFCdc4R485A into SCFCdc4 reactions also partially im-
paired elongation of ubiquitin chains on Sic1 in vitro
(Figure 4B).
The compromised activity of monomeric SCFCdc4 to-
ward Sic1 might readily be explained by defective sub-
strate recruitment. For example, both binding sites of
the dimer might simultaneously engage Sic1 and thereby
multiplicatively increase the affinity of the interaction. We
therefore assessed the ability of wild-type Cdc4 and mo-
nomeric Cdc4263–744 to interact with phospho-Sic1 in a
competitive binding assay. Equal molar amounts of Cdc4
and Cdc4263–744 were pre-mixed in solution then captured
by an equimolar amount of phospho-Sic1 immobilized on
resin. As judged by total protein stain, equivalent amounts
of full-length Cdc4 and Cdc4263–744 were recovered on
the phospho-Sic1 resin (Figure 4C). A similar result was
obtained with the Cdc4L250E/V251E double point mutant
(Figure S5A). To rigorously compare the affinity of dimeric
verses monomeric SCFCdc4 for phospho-Sic1, we devel-
oped a quantitative competition fluorescence polarization
assay, in which phospho-Sic1 was used to compete away
a fluorescently labeled high-affinity CPD peptide. As mea-
sured by loss of fluorescence polarization signal, phos-
pho-Sic1 exhibited a Ki of 3.2 ± 0.1 mM for Cdc41–744
and 3.6 ± 0.1 mM for Cdc4263–744 (Figure 4D). The affinities
of monomeric versus dimeric forms of Cdc4 for phospho-
Sic1 were thus indistinguishable in qualitative and quanti-
tative assays.
A High-Affinity CPD Ameliorates the Requirement
for SCFCdc4 Dimerization
Given that SCF dimerization appears to help overcome
suboptimally positioned lysine acceptor residues, whether
in Sic1 itself or in the extending ubiquitin chain, we sought
to find a situation in which monomeric SCFCdc4 could ef-
fectively eliminate Sic1. To this end we tested Sic1CPD,
a version of Sic1 in which the high-affinity LLTPP core
CPD from cyclin E precisely substitutes the five residues
centered on the Ser76 CPD site of Sic1, in the absence
of all of the eight other natural Sic1 CPD sites (Nash
et al., 2001). Sic1CPD is efficiently ubiquitinated by wild-
type SCFCdc4 in vitro and is eliminated precociously in vivo
(Nash et al., 2001). We note that the Sic1CPD construct
contains neither phosphorylatable nor acidic residues at
the +4 position; these residues are known to facilitate
cyclin E recognition by human Cdc4 (Welcker et al.,
2003; Ye et al., 2004). Unlike wild-type Sic1, Sic1CPD
was readily converted into high-molecular-weight species
by SCFCdc4(L250E/V251E) (Figure 5A, upper panel). Notably,
Cdc4L250E/V251E was itself markedly ubiquitinated com-
pared to wild-type Cdc4, again confirming that the
Figure 4. SCFCdc4 Dimerization Is Not Required for Substrate Binding
(A) The indicated CDC4 alleles were expressed from the GAL1 promoter on a 2 mm plasmid in cdc4-1 strain on either galactose medium at 30C or
glucose medium at 25C for 3 days. DIC images were taken 3 hr after galactose induction at 30C. Protein levels were determined by Ni-NTA resin
capture of each overexpressed protein followed by anti-Cdc4 immunoblot.
(B) Recombinant SCFCdc4 and SCFCdc4(R485A) complexes were purified from coinfected insect cells, mixed and equilibrated under reaction conditions
at 30C for 30 min, then assessed for activity against phosphorylated Sic1.
(C) Phosphorylated His6Sic1 immobilized on Ni-NTA resin was incubated at 4C with solution mixtures of recombinant monomeric Skp1-Cdc4263–744
and dimeric Skp1-Cdc4 complexes at the indicated stoichiometries, washed, and stained for total protein. The black line indicates where irrelevant
lanes have been cropped from the gel image.
(D) Recombinant monomeric Skp1-Cdc4263–744 and dimeric Skp1-Cdc41–744 complexes (0.3 mM) were bound to high affinity 9-mer CPD peptide de-
rived from cyclin E (GLLpTPPQSG; Kd for Skp1-Cdc4
263–744 = 0.22 ± 0.03 mM; Kd for Skp1-Cdc4
1–744 = 0.36 ± 0.06 mM). Phospho-Sic1 was titrated
against the complex and fluorescence polarization determined. Estimated Ki values for each complex are shown.complex was catalytically active (Figure 5A, lower panel).
Autoubiquitination of Cdc4 required sequences N-termi-
nal to the D domain and correlated with Cdc4 instability
in vivo (Figures S5B and S5C). The ability of Sic1CPD to by-
pass the dimerization requirement wasmanifest in vivo, as
replacement of endogenous SIC1with SIC1CPD bypassedthe growth defect of a cdc4-1 strain bearing a cdc4263–744
allele (Figure 5B). To rule out possible differences in Cdc4
interaction affinity, we coupled phosphorylated Sic1 or
Sic1CPD to low-density sensor chips (Biacore CM4) and
measured the surface plasmon resonance (SPR signal)
due to capture of Skp1-Cdc4 from solution phase. Sic1Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc. 1171
Figure5. SubstratePositioning Influences
the Requirement for SCF Dimerization
and Processivity of the Ubiquitination
Reaction
(A) A single high-affinity CPD site in Sic1 by-
passes the requirement for SCF dimerization
in vitro. Ubiquitination of either Sic1 or Sic1CPD
was carried out with either SCFCdc4 or
SCFCdc4 (L250E/V251E) for 1 hr. Products were de-
tected with anti-Sic1 and anti-Cdc4 polyclonal
antibodies. The black line indicates where irrel-
evant lanes have been cropped from the gel
image.
(B) Complementation of the cdc4-1 defect at
the nonpermissive temperature by overpro-
duction of either CDC4 or CDC4263–744 from
the GAL1 promoter, in the context of either a
wild-type SIC1 or a SIC1CPD integrated allele.
Strains were incubated on either galactoseme-
dium at 34C or glucose medium at 25C for
3 days.
(C) Quantitative determination of Sic1-Cdc4
interaction affinity by surface plasmon reso-
nance. Recombinant phosphorylated Sic1 or
Sic1CPD was coupled to a low-density Biacore
surface and analyzed for interaction kinetics
with Skp1-Cdc4263–744. Values shown are the
average of two independent experiments; all
variations were less than 20% of the average.
Raw traces for on and off rate determination
are shown in Figure S6.
(D) Position of acceptor lysines in Sic1 affects
initiation efficiency of SCFCdc4-mediated ubiq-
uitination. Sic1 derivatives that lacked all natural CDK phosphorylation sites and contained only the indicated acceptor lysine residues were tethered
to Cdc4 by a high-affinity CPD site at the extreme N terminus. Each derivative was incubated with dimeric SCFCdc4 under reaction conditions for the
indicated periods of time.and Sic1CPD bound to monomeric Skp1-Cdc4 with very
similar on and off rates and hence had similar overall dis-
sociation constants of approximately 0.25 mM (Figures 5C
and S6). Positioning of a substrate degron can thus affect
the requirement for dimerization in the absence of effects
on Cdc4 interaction affinity.
Effective Catalytic Gap Distance in SCFCdc4
To investigate the role of relative substrate positioning in
catalysis, we created a series of Sic1 derivatives based on
a template that contained a single high-affinity CPD site at
the extreme N terminus in the absence of all other CPD
sites. A series of defined acceptor lysines was created
by ablating all lysines in the N-terminal region except for
pairs of lysines at positions 1/2, 32/36, 50/53, and
84/88. Thismolecular ruler enabled us to establish the bio-
chemical requirement to bridge the substrate-binding
site-to-catalytic site gap in the context of a full-length
substrate. Each derivative was phosphorylated and then
subjected to ubiquitination by dimeric SCFCdc4. Although
a minor amount of polyubiquitination was observed for
each of the acceptor sites, only Lys84/88 supported an
efficient initial conjugation reaction (Figure 5D). After the
initial burst of addition to Lys84/88, however, further con-
version to high-molecular-weight conjugates was de-
layed. Effective access of the bound substrate to the E21172 Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc.catalytic site thus required an extension on the order of
80 residues.We note that this lengthwell exceeds themin-
imal requirement of 14 residues for catalytic site access of
b-catenin phosphopeptides (Wu et al., 2003); it may be
that in the context of a large disordered polypeptide such
as Sic1, ubiquitin conjugation at more proximal sites is
suppressed. The capacity to differentially orient a bound
substrate through multiple degrons is apparently critical
for efficient catalysis.
Suprafacial Configuration of the SCF Dimer
As we were unable to crystallize even minimal constructs
that contain the adjacent D domain and F box domains
(data not shown), we used SAXS analysis of the dimeric
Skp1-Cdc4 complex in solution to constrain the possible
relative orientations of the Skp1-Cdc4263–744 monomer
(Orlicky et al., 2003) and the D domain dimer (solved
above). Guinier plots derived from SAXS data collected
for both monomeric Skp1-Cdc4263–744 and dimeric
Skp1-Cdc4222–744 indicated that the solutionswere largely
monodisperse (Figure 6A). Based on the Guinier plots, we
determined Rg values of 34.9 A˚ and 46.3 A˚ for Cdc4
263–744
and Cdc4222–744, respectively. Rg values and maximal
dimensions were also determined from the distance distri-
bution function by indirect transform of all of the SAXS
data (Semenyuk and Svergun, 1991): this method yielded
Figure 6. Model of the Dimeric SCFCdc4
Complex Determined by SAXS in Solu-
tion
(A) Guinier analysis for SAXS data collected
from (i) Skp1-Cdc4263–744 and (ii) Skp1-
Cdc4222–744. The complete measured scatter-
ing data are shown by the solid line and the
data used for determination of the slope are
indicated by filled circles. Least squares linear
fits to the latter are indicated by the dashed
lines; the slopes of these lines are equal to
Rg
2/3. Data were scaled such that the I(0) is
equal to 1.
(B) Theoretical scattering from models of mo-
nomeric Skp1-Cdc4263–744 and dimeric Skp1-
Cdc4222–744 compared to experimental SAXS
data. (i) A complete model for monomeric
Skp1-Cdc4263–744 in solution was constructed
based on the known crystal structure (Orlicky
et al., 2003). Theoretical solution scattering
from the model (red curve) was compared to
observed SAXS data (crosses). (ii) Calculated
solution scattering for the model of dimeric
Skp1-Cdc4222–744 (red curve) compared to ob-
served SAXS data (crosses) is shown. In this
model, which yields the best fit to the solution
scattering data (see Figure S7 for less-optimal
models), the D domain is located between,
and makes extensive contacts with, Skp1 and
the F box domain.
(C) Stereo ribbons representation of the SAXS
solution-based model of the dimeric Skp1-
Cdc4222–744 subcomplex.
(D) Space-filling representation of the dimeric
SCFCdc4 complex. Calculated distances be-
tween substrate-binding sites and catalytic
sites are shown.an Rg of 35.5 A˚ and a maximal dimension of 110 A˚ for
Cdc4263–744 and an Rg of 47.2 A˚ and a maximal dimension
of 140 A˚ for Cdc4222–744. The Rg values determined using
the two methods, as well as the consistency of the SAXS
data with the crystal structure of the Cdc4 monomer
(Figure 6B), enabled us to model the Skp1-Cdc4 dimer
with confidence (see Supplemental Data and Figure S7
for discussion of suboptimal models).
When fitted with the X-ray structures of the Skp1-Cdc4
monomer and the D domain, the SAXS data for the Skp1-
Cdc4 dimer unambiguously constrained the possible
orientations of each Skp1-Cdc4 monomer to a side-by-
side or suprafacial configuration, i.e., with the substrate-
binding sites facing in the same general direction (Fig-
ure 6C). The fitted model of the Skp1-Cdc4 dimer was
then extended to the entire SCFCdc4 complex (Figure 6D).
As oriented in this manner, the substrate-binding site-
to-substrate-binding site distance between the WD40 do-
mains of each Cdc4 subunit was nominally 65 A˚. The dis-
tance between the substrate-binding site and the Cdc34
catalytic center was approximately 102 A˚ for the intermo-
nomer interaction, as compared to the 64 A˚ gap modeled
previously for the intramonomer interaction (Orlicky et al.,
2003). The overall geometry of the dimeric complex lo-
cated the adjacent substrate-binding sites in betweenthe two catalytic centers. Given that the mean path length
for a disordered polypeptide of 90 residues such as the
N-terminal targeting domain of Sic1 is approximately 30
A˚ (Klein et al., 2003), we note that it is unlikely that Sic1
would be able to simultaneously engage both substrate-
binding sites. This interpretation is consistent with the
similar affinities of the monomeric and dimeric forms of
Cdc4 for Sic1 (Figures 4C, 4D, and S5A). As described
below, the SAXS model provides a basis for interpreting
the biochemical requirements for SCF dimerization.
DISCUSSION
Dimerization mediated by the D domain is essential for
function of the WD40 subclass of F box proteins. Our
structural analysis of the isolated D domains of Cdc4
and b-TrCP in conjunction with the SAXS-based structure
of the intact Skp1-Cdc4 dimer reveals that the D domain
orients the substrate-binding domain and E2-binding
site of each SCF protomer in a suprafacial configuration.
Dimerization of the SCF complex does not appear to
overtly affect either catalytic competence or affinity for
substrates but rather appears to facilitate lysine acceptor
site utilization.Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc. 1173
D Domain Specificity
The isolated D domain engages primarily in homotypic
interactions, in accord with the known homotypic interac-
tions of some F box proteins (Kominami et al., 1998; Pat-
ton et al., 1998; Wolf et al., 1999; Suzuki et al., 2000;
Dixon et al., 2003). These homotypic preferences may
preclude dominant interfering effects of one F box protein
on another. As shown by the interfering effect of
Cdc4R485A overexpression on yeast growth, SCF dimer-
ization also raises the specter of dominant-negative
effects of cancer-associated mutations in human Cdc4
(Moberg et al., 2001; Strohmaier et al., 2001; Spruck
et al., 2002; Rajagopalan et al., 2004). The spatial require-
ments for SCF dimerization are not overly stringent, as
illustrated by the partial complementation of D domain
function by GST-mediated dimerization. Thus, the precise
interprotomer distances separating the E2 catalytic and
substrate-binding sites may not be critical, as opposed
to the need for variable substrate-to-E2 distance options.
SCF Dimerization and Catalytic Efficiency
The dimeric SCF complex affords two quite different
substrate-to-catalytic site separation distances, namely
an intraprotomer gap of 64 A˚ and an interprotomer gap
of 102 A˚. The substantial difference between these two
gap distances would readily accommodate various ac-
ceptor sites and chain geometries. This notion is sup-
ported by the effect of dimerization on both initiation and
elongation steps in various contexts. For example, the
rapid conversion of di- and triubiquitin intermediates on
Sic1(K36) to longer, less tractable products is consistent
with a defect in chain elongation. The importance of ap-
propriate catalytic gap distances is also manifest in the
strong preference for an80 residue distance for efficient
initiation on the Sic1-based molecular ruler.
Recent enzymatic studies have shown that SCFCdc4-
mediated ubiquitination of Sic1 proceeds via an initial
rate-limiting conjugation step followed by rapid elongation
of the ubiquitin chain (Petroski and Deshaies, 2005b). Our
kinetic analysis suggests that SCFCdc4 dimerization is par-
ticularly crucial for efficient chain elongation. Juxtaposi-
tion of two E2 sites in proximity to the substrate in the
suprafacial structure may also increase reaction kinetics
via E2 loading and unloading at alternate sites (Varelas
et al., 2003; Eletr et al., 2005). We note that the elongation
reaction also requires an acidic loop insertion in Cdc34
that appears to mediate a low-affinity noncatalytic site in-
teraction between Cdc34 and the extending ubiquitin
chain (Petroski and Deshaies, 2005b).
Multiple substrate orientations are also likely to engen-
der efficient catalysis. Ubiquitination reactions performed
with monomeric SCFCdc4, wild-type Sic1, and Ub(K48R)
exhibit a much more modest defect in initiation as com-
pared to those performed with Sic1(K36) and Ub(K48R).
In wild-type Sic1, the multiple lysines available for initia-
tion could increase reaction rate by two possible means:
(1) if one or more sites are better positioned than K36,
such sites would increase reaction kinetics and/or (2)1174 Cell 129, 1165–1176, June 15, 2007 ª2007 Elsevier Inc.even if no lysines were more favored than K36, the avail-
ability of five additional targeting lysines in wild-type Sic1
would drive the reaction simply due to the increased prob-
ability of a productive interaction with the ubiquitin thio-
ester onCdc34. As each acceptor lysine in the flexible Sic1
N terminus can be positioned by any one of seven different
weak CPD sequences, the contribution of such sampling
effects on both initiation and elongation may be substan-
tial (Petroski and Deshaies, 2003; Petroski et al., 2006).
The interplay of SCF dimerization andmultiple site posi-
tioning likely facilitates ubiquitination of other substrates
including Gcn4 and Far1, which each contain both high-
and low-affinity CPD elements (Chi et al., 2001; Nash
et al., 2001). A host of substrate types are targeted by
theWD40 class of F box proteins in other species, ranging
from those targeted primarily by dedicated high-affinity
sites, such as Met4, b-catenin, and IkBa (Dixon et al.,
2003; Wu et al., 2003), to those targeted by multiple
weak sites, such as dMyc and Ci (Moberg et al., 2004;
Jia et al., 2005), to intermediate cases such as cyclin E
(Welcker et al., 2003; Ye et al., 2004). Interestingly,
SCFMet30 appears to bind a single dedicated site on
Met4 and to ubiquitinate a single acceptor lysine residue,
suggesting that the dimerization requirement may not be
intrinsic to multisite-dependent substrates (Flick et al.,
2004). SCF dimerization may thus be a frequent or even
general catalytic feature.
Higher-Order Ubiquitin Ligase Structure
How pervasive is the role of dimerization, or multimeriza-
tion, in E3 function? In fission yeast, the two Cdc4 homo-
logs Pop1 and Pop2 form homo- and heterodimers, the
latter of which appear to be essential for activity in vivo
(Kominami et al., 1998; Wolf et al., 1999). Human Cdc4/
Fbw7 also dimerizes via its D domain, which is required
for elimination of cyclin E when ancillary targeting sites
are compromised (Welcker and Clurman, 2007). Other
CRLs also appear to act as dimers, including Cul2-VHL
(Chung et al., 2006), Cul3-BTB (Pintard et al., 2004), and
APC/C complexes (Passmore et al., 2005); intriguingly,
hypothetical Cul3-BTB models also suggest an overall
suprafacial geometry (Stogios et al., 2005; see Figures
S8A and S8B). Finally, other unrelated E3 enzymes form
higher-order structures via different multimerization do-
mains, including Hdm2 (Kostic et al., 2006) and Prp19
(Vander Kooi et al., 2006). The biochemical and structural
requirements for D domain-mediated SCF dimerization
described here suggest that intrinsic variability in sub-
strate-to-catalytic site distances may be a general operat-
ing principle of ubiquitin ligases.
EXPERIMENTAL PROCEDURES
Yeast Manipulations
Strains and plasmids are listed in Tables S1 and S2. Standardmethods
for cell culture were as described (Nash et al., 2001; Orlicky et al.,
2003). Yeast extraction, immunoblots, and immunoprecipitation were
also as described (Patton et al., 1998).
Protein Interactions and In Vitro Ubiquitination
Recombinant D domain fragments (Cdc4222–273, b-TrCP92–143,
Met30133–182, and Vts1186–237), Sic1 and Skp1-Cdc4 complexes, and
other recombinant proteins were produced either in bacteria or insect
cells, and protein interactions detected as described (Nash et al.,
2001; Orlicky et al., 2003; Tang et al., 2005). SPR was performed on
a Biacore 2000 instrument (see Supplemental Data). Sic1 and other
SCFCdc4 candidate substrates were ubiquitinated with recombinant
SCFCdc4 complexes produced in insect cells as described (Tang
et al., 2005). For time course series, SCFCdc4 and SCFCdc4 (L250E/L251E)
were double purified using affinity tags on Rbx1 (HIS6) and Cdc4
(FLAG). Ubiquitination reactions contained 0.2 mM E1(Uba1), 1 mM
Cdc34, 0.2 mM SCFCdc4 or SCFCdc4 (L250E/L251E), 0.1 mM pSic1, 12 mM
ubiquitin or ubiquitinK48R, 2 mM ATP, 10 mMMgCl2, 50 mM NaCl, and
50 mM Tris-HCl (pH 7.5) and were carried out at 30C.
Crystallization, Data Collection,
Structure Determination, and Modeling
D domain fragments from S. cerevisiae Cdc4 (residues 222–273) and
from human b-TrCP (residues 92–143) were produced as GST fusions
and labeled with seleno-methionine in B834(DE3) bacterial cells (Stra-
tagene). D domains were bound to GSH-Sepharose 4B resin, released
by TEV protease digestion, and purified on Q-Sepharose and Sepha-
dex S75 columns. Peak fractions were concentrated to 30 mg/ml
(Cdc4) or 80 mg/ml (b-TrCP) in 10 mM HEPES (pH 7.5), 150 mM
NaCl, and 1mMDTT. Cdc4D domain crystals were obtained bymixing
equal volumes of protein with 100 mM Tris (pH 8.5), 100 mM ammo-
nium phosphate dibasic (Sigma), and 50% 2-methyl-2,4-pentanediol
(Hampton Research) (space group P61; a = b = 37.87 A˚, c = 298.1 A˚,
a = b = 90, g = 120). A Single Anomalous Dispersion (SAD) experi-
ment was performed on beamline 19-BM (Advanced Photon Source,
Argonne, IL) at 0.9788 A˚. Structure refinement was to a final resolution
of 2.5 A˚ with a Rwork = 23.1% and Rfree = 27.4%. b-TrCP D domain
crystals were obtained by mixing equal volumes of protein with 100
HEPES (pH 7.5), 200 mM MgCl2, and 5 mM CdCl2 (space group
P43212; a = b = 71.3 A˚, c = 116.3 A˚, a = b = g = 90
). A SAD experiment
was carried out on beamline 8-BM at 0.97906 A˚. Structure refinement
was to a final resolution of 2.4 A˚ with a Rwork = 24% and Rfree = 26.7%.
SAXS Analysis
SAXS data were collected at BioCAT beamline ID-18 (Advanced Pho-
ton Source). Prior to data collection, purified Skp1-Cdc4222–744 and
Skp1-Cdc4263–744 were separated from aggregates on a SD200 HR
10/30 column in 10 mM HEPES pH 7.5, 250 mM NaCl, and 1 mM
DTT. CRYSOL was used to compare experimental solution scattering
data to theoretical scattering from atomic models (Svergun et al.,
1995); SASREF was used to identify symmetric dimer solutions of
the Skp1-Cdc4263–744 monomer that were compatible with SAXS
data for the Skp1-Cdc4222–744 dimer (Petoukhov and Svergun, 2005).
The dimeric holo-SCFCdc4 model was generated from a monomeric
holo-SCFCdc4(263–744) model (Orlicky et al., 2003), as constrained by
the SAXS-based model of the dimeric Cdc4222–744-Skp1 complex. De-
tails of SAXS data analysis and model construction are provided in the
Supplemental Data.
Supplemental Data
Supplemental Data include Experimental Procedures, Supplemental
References, eight figures, and two tables and can be found with this
article online at http://www.cell.com/cgi/content/full/129/6/1165/
DC1/.
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